MyAverix Finance
F · Healthcare
GH RESEARCH PLC DL-025 (1KA)
Biotechnology
GH RESEARCH PLC DL-025 (1KA) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-22, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 1KA
GH RESEARCH PLC DL-025 (1KA) — FAQ
What is 1KA's P/E ratio?
The price-to-earnings (P/E) ratio for GH RESEARCH PLC DL-025 (1KA) is 18.00 (data as of 2026-03-22).
Does GH RESEARCH PLC DL-025 pay a dividend?
Dividend yield is not available in the current snapshot for GH RESEARCH PLC DL-025 (1KA). Check the MyAverix Finance app for the latest dividend data.
What sector is GH RESEARCH PLC DL-025 in?
GH RESEARCH PLC DL-025 (1KA) is classified in the Healthcare sector (Biotechnology industry).
What exchange is 1KA listed on?
1KA is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.